Novozymes B Surges in Q1 2025 with 11% Sales Growth, Boosting Danish Stock Market
Novozymes B exceeded market expectations with an 11% organic sales growth in Q1 2025, sending its stock price soaring and solidifying its position as a top performer in the Danish stock market.
2 minutes to read